Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry
Autor: | Montilla, S., Marchesini, G., Sammarco, A., Trotta, M.P., Siviero, P.D., Tomino, C., Melchiorri, D., Pani, L. |
---|---|
Zdroj: | In Nutrition, Metabolism and Cardiovascular Diseases December 2014 24(12):1346-1353 |
Databáze: | ScienceDirect |
Externí odkaz: |